Remi Mito

SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma

Eri Matsubara, Yoshihiro Komohara, Shigeyuki Esumi et al. · Cancers · 2022 · 69 citations · Full text

Tumor-associated Macrophages, Lung Inflammation, Lung Adenocarcinoma +16

The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma

Yusuke Shinchi, Shiho Ishizuka, Yoshihiro Komohara et al. · Cancer Immunology Immunotherapy · 2022 · 48 citations · Full text

Cancer Immunosurveillance, Clinical Impacts, Lung Adenocarcinoma +9

Clinical impact of TROP2 in non‐small lung cancers and its correlation with abnormal p53 nuclear accumulation

Remi Mito, Eri Matsubara, Yoshihiro Komohara et al. · Pathology International · 2020 · 32 citations

CD163‐positive cancer cells are a predictor of a worse clinical course in lung adenocarcinoma

Eri Matsubara, Yoshihiro Komohara, Yusuke Shinchi et al. · Pathology International · 2021 · 24 citations

Cancer Immunosurveillance, Cd163‐positive Cancer Cells, Medicine +14

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients

Koichi Saruwatari, Ryo Sato, Shunya Nakane et al. · Cancers · 2019 · 23 citations · Full text